Dark adaptation changes in highly myopic patients.


Journal

European journal of ophthalmology
ISSN: 1724-6016
Titre abrégé: Eur J Ophthalmol
Pays: United States
ID NLM: 9110772

Informations de publication

Date de publication:
May 2019
Historique:
pubmed: 1 8 2018
medline: 28 7 2019
entrez: 1 8 2018
Statut: ppublish

Résumé

The objective of this study was to determine whether the dark adaptation time was longer in highly myopic patients than in emmetropic patients and whether there was a correlation between dark adaptation results and axial length. We conducted a retrospective study that included highly myopic patients with -6.00 dioptres or more, matched to emmetropic control patients of the same age. All patients underwent an automated adaptometry protocol that calculates the rod intercept that reflects rod-mediated dark adaptation. Axial length was measured. Colour photographs were taken to look for retinal atrophic lesions. A total of 25 highly myopic patients and 25 control patients were included. The mean rod intercept was 4.38 (±1.60) min in the myopic patients and 4.27 (±1.41) min in the control patients. This difference was not statistically significant ( p = 0.79). However, in myopic patients, the longer the axial length was, the longer the dark adaptation time was ( p = 0.0003). In addition, dark adaptation was significantly longer in myopic patients with retinal pigment epithelium atrophy than in patients without lesions ( p = 0.0398). In this study, dark adaptation time did not significantly differ between myopic patients and controls but was correlated with axial length in patients with severe myopia and was significantly longer in the presence of retinal pigment epithelium atrophic lesions.

Identifiants

pubmed: 30060691
doi: 10.1177/1120672118790194
doi:

Types de publication

Journal Article

Langues

eng

Pagination

287-294

Auteurs

Arnaud Messerlin (A)

Department of Ophthalmology, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France.

Mathieu Greth (M)

Department of Ophthalmology, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France.

Tristan Bourcier (T)

Department of Ophthalmology, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France.

Arnaud Sauer (A)

Department of Ophthalmology, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France.

Claude Speeg-Schatz (C)

Department of Ophthalmology, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France.

David Gaucher (D)

Department of Ophthalmology, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH